Company Filing History:
Years Active: 2022
Title: Yumi Oh - Innovator in Cancer Treatment
Introduction
Yumi Oh is a prominent inventor based in Goyang-si, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development of chimeric antigen receptors.
Latest Patents
Yumi Oh holds a patent for a chimeric antigen receptor to which an anti-cotinine antibody is linked. This invention relates to chimeric antibody receptors that can effectively target and induce cell death in cancer cells. The T cells presenting this chimeric antibody receptor secrete interferon gamma specifically for a target molecule of a cotinine-conjugated binding molecule. This mechanism allows for the targeted destruction of cancer cells while also providing a method to manage potential immune side effects.
Career Highlights
Yumi Oh is affiliated with Seoul National University, where she conducts her research. Her work focuses on the intersection of immunology and cancer therapy, aiming to develop safer and more effective treatment options for patients.
Collaborations
Yumi collaborates with notable colleagues, including Kyungho Choi and Hyung-Bae Park, who contribute to her research efforts and advancements in the field.
Conclusion
Yumi Oh's innovative work in developing chimeric antigen receptors represents a significant advancement in cancer treatment. Her contributions are paving the way for more effective therapies that can improve patient outcomes.